IBM and Nvidia move quantum processors into supercomputing workflows
New Slurm integration, a Fermilab co-design platform and GPU-accelerated error-correction tools aim to make quantum processors usable inside established HPC environments.
Quantum / NEWS BRIEF
The University of Chicago-hosted installation gives the region a locally operated 120-qubit Nighthawk system for research and industry projects before its eventual move to Illinois's quantum campus.
IBM Quantum System Two is now operating at Hyde Park Labs near the University of Chicago, making it IBM's first quantum computer installed in Illinois. IBM and the university say the machine is powered by a 120-qubit Nighthawk processor with 218 tunable couplers. It will anchor the National Quantum Algorithm Center while the Illinois Quantum and Microelectronics Park is built, then move to the permanent campus.
The center is intended to bring university researchers, national laboratories, startups and companies together with IBM scientists. Named projects include molecular-simulation work involving AbbVie, Deloitte and Northwestern University, power-grid optimization with EPRI and the University of Illinois Urbana-Champaign, and high-energy-physics research with Fermilab. The physical installation therefore adds usable regional infrastructure rather than merely announcing another partnership.
IBM calls Nighthawk its most powerful chip and says the system can produce scientifically useful results, but the Nov. 6 unveiling did not report a new peer-reviewed computation, error-rate record or independently verified advantage over classical methods. Its significance is deployment and access: a current-generation IBM system is available inside a coordinated research ecosystem. Claims about practical superiority still require task-specific evidence.
New Slurm integration, a Fermilab co-design platform and GPU-accelerated error-correction tools aim to make quantum processors usable inside established HPC environments.
OpenAI has released healthcare-focused computer-use capabilities across its API and clinical products, with configurable approvals, audit logs and new performance results that remain provider-reported.